GENERATION OF AN INNOVATIVE CONJUGATED ANTICORPO-FARMACO NON INTERNAL ANTE MONOCLONAL ANTIBODIES DEFINED AS SPECIFIC TARGET MEDICINAL PRODUCTS (TARGETED THERRANO DEMONSTRATED A LOW LEVEL OF POTENCY IN THE TREATMENT OF SOLID TUMOURS. A WAY TO INCREASE THE THERAPEUTIC POTENTIAL OF MONOCLONAL ANTIBODIES? Qshare on FacebookTwitterLinkedinEmailreport an issue